TG Therapeutics Inc (TGTX) Stock Price, Quote, News & History

TGTXNASDAQ
$54.87
-0.06-0.11%
At close: Jul 17, 5:00 PM EST
$54.94
0.07370.13%
After Hours: Jul 17, 4:18 PM EST
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-13.95M
Investing Cash Flow (TTM)
16.87M
Financing Cash Flow (TTM)
307.20M
Free Cash Flow (TTM)
-14.19M
Capital Expenditure (TTM)
-240.00K
Net Change in Cash (TTM)
310.12M

Analyst Trends and Forecast

1
Feb
2
May
2
1
Jul
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.5
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$8.64B
PE Ratio (TTM)
19.22
PE Ratio (FWD)
58.48
PEG Ratio (TTM)
-
PS Ratio (TTM)
12.61
PB Ratio (TTM)
14.43
Earnings Yield % (TTM)
5.20%
Earnings Yield % (FWD)
1.71%
EV / EBITDA (TTM)
57.61
Price / EBITDA (TTM)
58.82
Price / Free Cash Flow (TTM)
-
Book Value / Share
$3.81

Company Debt

Total Debt
$745.14M
LT Debt
$745.14M
LT Debt Issuance (TTM)
$747.66M
LT Debt Repayment (TTM)
-$255.00M
Total Cash
$442.21M
Debt to Equity
1.29
Issuance of Debt (TTM)
$492.66M
Repayment of Debt (TTM)
-$255.00M

Key Statistics

Open
$54.25
Close
$54.87
Volume / Avg.
3.41M / 2.40M
Day Range
$53.54 - $55.78
52 Wk Range
25.28 - 59.30
Market Cap
$8.41B
P/E Ratio
19.22
Dividend Yield
-
Exchange
NASDAQ
RSI
58
Short Interest
28.48%
Days to Cover
8.29

About

Sector
Health Care
Industry
Biotechnology
TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval fr...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy TG Therapeutics (TGTX) stock?

A

You can purchase shares of TG Therapeutics (NASDAQ:TGTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are TG Therapeutics (TGTX) competitors?

A

There are no as such competitors for TG Therapeutics.

Q

What is the forecast, or price target, for TG Therapeutics (TGTX) stock?

A

TG Therapeutics has a consensus price target of $45.30.

Q

What is the current price for TG Therapeutics (TGTX)?

A

The stock price for TG Therapeutics (NASDAQ: TGTX) is $54.9437 last updated July 17, 2026 at 4:18 PM EDT.

Q

Does TG Therapeutics (TGTX) pay a dividend?

A

There are no upcoming dividends for TG Therapeutics.

Q

When is TG Therapeutics (NASDAQ:TGTX) reporting earnings?

A

TG Therapeutics does not have any upcoming earnings scheduled.

Q

Is TG Therapeutics (TGTX) going to split?

A

There is no upcoming split for TG Therapeutics.

Q

What sector and industry does TG Therapeutics (TGTX) operate in?

A

TG Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.